Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Defined term · Institutional

Assessment cycle

The quarterly period in which the Institute ratifies documents. Every document carries the cycle in which its current version was ratified.

Document identifier
CEI-GT-184
Series
Defined term
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Assessment cycle

§1.1Also known as

Cycle

§1.2Category

Institutional — Terms with a specific meaning inside the Institute’s document set.

§1.3Related terms

  • Ratification — Approval of a document by the assessment committee following external review and, where applicable, the disposition of a public comment period. A document is published…
  • Next review — The cycle in which a document is scheduled for re-examination. A document past its next-review date without a new version is flagged in the registry.
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.